← Back to Search

Cycling Groups for Parkinson's Disease

N/A
Recruiting
Led By Kristen A Pickett, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-test (~6-months), 3-month follow up (~9-months)
Awards & highlights

Study Summary

This trial will study an at-home, progressive cycling program for people with Parkinson's Disease to see if it's effective and how social support affects it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-test (~6-months), 3-month follow up (~9-months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-test (~6-months), 3-month follow up (~9-months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Canadian Occupational Performance Measure (COPM) scores
Gait
Change in Standardized Gait Analysis: Gait Velocity
+2 more
Secondary outcome measures
Change in Activity Level Measured by Number of Steps Taken per day
Accidental Falls
Change in Four Square Step Test
+2 more
Other outcome measures
Change in Free Locomotion Gait Analysis: Acceleration
Gait
Change in Free Locomotion Gait Analysis: Relative Distance
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Study 2: Solo Cycling GroupExperimental Treatment1 Intervention
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to cycling without a partner for a target duration and intensity.
Group II: Study 2: Social Cycling GroupExperimental Treatment1 Intervention
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to 30 minutes of cycling while engaged in social interaction with a research staff member, thus providing a social/community aspect that would not otherwise be present.
Group III: Study 1: Social Cycling GroupExperimental Treatment1 Intervention
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to 30 minutes of cycling while engaged in social interaction with a research staff member, thus providing a social/community aspect that would not otherwise be present.
Group IV: Study 1: Normal Care Control GroupActive Control1 Intervention
Study 1: Normal Care Control Group [will crossover and complete the cycling intervention following the initial 6-months]

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
323 Previous Clinical Trials
401,504 Total Patients Enrolled
University of Wisconsin, MadisonLead Sponsor
1,193 Previous Clinical Trials
3,161,817 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,720 Previous Clinical Trials
7,494,175 Total Patients Enrolled

Media Library

Social Cycling Group Clinical Trial Eligibility Overview. Trial Name: NCT04300023 — N/A
Parkinson's Disease Research Study Groups: Study 2: Solo Cycling Group, Study 1: Social Cycling Group, Study 2: Social Cycling Group, Study 1: Normal Care Control Group
Parkinson's Disease Clinical Trial 2023: Social Cycling Group Highlights & Side Effects. Trial Name: NCT04300023 — N/A
Social Cycling Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT04300023 — N/A
~14 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top